2024-09-07 - Analysis Report
## TMO Stock Analysis Report

**Company Overview:** TMO, Thermo Fisher Scientific Inc., is a global leader in providing analytical instruments, laboratory equipment, consumables, and services for life sciences, diagnostics, and applied markets.

**Performance Analysis:**

1. **Return on Investment (ROI) Comparison:**
    * TMO's cumulative return is 114.73%.
    * The S&P 500 (VOO) cumulative return is 89.66%.
    * TMO outperformed the S&P 500 by 25.07 percentage points. This places TMO's performance at the 29.58th percentile within the historical range of performance differences between TMO and the S&P 500. 

2. **Recent Price Movements:**
    * **Closing Price:** $615.07
    * **5-day Moving Average:** $611.18
    * **20-day Moving Average:** $604.74
    * **60-day Moving Average:** $578.32
    * The recent price movement indicates a slight upward trend, with the closing price above all three moving averages.

3. **Technical Indicators:**
    * **RSI:** 67.56 - The RSI suggests the stock is in the overbought territory, potentially indicating a short-term correction may be due.
    * **PPO:** -0.13 - The PPO indicates a slight bearish momentum, suggesting a potential slowdown in price growth.
    * **Delta_Previous_Relative_Divergence:** -11.79 - The negative value suggests a short-term downward trend in the relative price divergence, indicating a potential decrease in outperformance against the market.
    * **Expected Return:** 61.82% - The expected return represents the potential return over a 5-year period, suggesting a strong potential for long-term growth.

4. **Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The most recent earnings report (2024-08-02) shows an EPS of 4.05 and revenue of 10.54B$. This represents a slight decrease in EPS compared to the previous quarter, but the revenue is still strong and indicates a healthy growth trend. The overall earnings performance remains positive, although further analysis is needed to assess specific drivers and potential future outlook.

**Conclusion:**

TMO has historically outperformed the S&P 500, demonstrating strong performance. Recent price movements suggest a slight upward trend, but technical indicators suggest the stock might be overbought and experiencing a slight bearish momentum. Strong recent earnings and revenue performance indicate a healthy growth trend, but further analysis is needed to assess the future outlook.  Overall, TMO remains a promising investment with the potential for continued growth, although short-term price corrections should be monitored. 
